DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves premarket: Eli Lilly, Caterpillar, VinFast, Alphabet and more
▼ + stars: | 2024-10-30 | by ( Alex Harring | ) www.cnbc.com time to read: +4 min

Eli Lilly — The drug maker tumbled 7.5% after missing analyst expectations for the third quarter and cutting full-year guidance. Eli Lilly earned $1.18 per share, excluding items, on $11.44 billion in revenue. Analysts polled by LSEG had anticipated earnings of $1.47 a share and $12.11 billion in revenue. Caterpillar — Shares fell more than 5% in the premarket after the industrial giant reported weaker-than-expected earnings for the third quarter. The company posted a profit of $5.17 per share, while analysts polled by LSEG had forecast earnings of $5.34 per share.

Persons: Eli Lilly, LSEG, XPO, FactSet, Qorvo, Raymond James, Reddit, —, Jesse Pound, Sarah Min, Sean Conlon, Michelle Fox, Samantha Subin, Fred Imbert Organizations: Caterpillar, Revenue, Bloomberg, Emirates, Google, Visa, AMD

☆ Jim Cramer looks at what to do with Eli Lilly, AMD shares after their big slides on earnings
▼ + stars: | 2024-10-30 | by ( Paulina Likos | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Meanwhile, fellow Club stock Advanced Micro Devices fell 9.5% on Wednesday, the morning after it issued light guidance. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Brian Niccol, Jim, Eli Lilly, Lilly, Stocks, Jim Cramer's Organizations: CNBC, Microsoft, Starbucks, Meta, Google, Club, Nvidia, AMD, GE Healthcare, Reddit Locations: China

☆ 3-Stock Lunch: Caterpillar, Eli Lilly & Carvana
▼ + stars: | 2024-10-30 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email3-Stock Lunch: Caterpillar, Eli Lilly & CarvanaVictoria Greene, G Squared Private Wealth, joins 'Power Lunch' to discuss stock plays for three stocks.

Persons: Eli Lilly, Victoria Greene Organizations: Wealth

CNN —Michigan prosecutors charged a Chinese citizen with voter fraud and perjury after he allegedly cast a ballot in the 2024 election, authorities announced Wednesday. Authorities said the man isn’t a US citizen, and therefore can’t vote in federal elections. Experts say illegal voting by non-citizens is extremely rare, and when it does happen, it is usually caught quickly. Authorities did not identify the Chinese student accused of voting in the election. Washtenaw County Clerk Lawrence Kestenbaum told CNN ballots can’t be retrieved once they have gone through the tabulator.

Persons: Donald Trump, Jocelyn Benson, Eli Savit, Dana Nessel, can’t, Lawrence Kestenbaum, Kestenbaum, “, ” Kestenbaum, ”, David Becker, Ciara Torres, ” Torres, Spelliscy, Michigan “ Organizations: CNN, University of Michigan, Authorities, Republican, Experts, “, ”, Michigan, Department, Election Innovation, Research, Michigan GOP, Stetson University Locations: Michigan, Ann Arbor, Washtenaw County, China, American

☆ Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. During an earnings call Wednesday, Eli Lilly instead blamed it on drug wholesalers cutting inventory of Zepbound and Mounjaro. On the earnings call, Eli Lilly executives insisted that underlying demand for the medicines remained strong. No," Eli Lilly CEO Dave Ricks said, pointing instead to "a lot of lumpiness in channel stocking." Ricks said Eli Lilly had yet to begin what the company calls "demand-stimulating activities," or advertising and promoting, for Zepbound.

Persons: Eli Lilly, Mounjaro, StreetAccount ., Geoff Meacham, Jared Holz, Mizuho, Carter Gould, Eli Lilly's, tirzepatide, Dave Ricks, Ricks, Lilly Organizations: U.S, StreetAccount, Citi, Barclays, Food and Drug, FDA Locations: Brooklyn, New York, Lilly

☆ Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. Eli Lilly now expects full-year adjusted earnings of between $13.02 and $13.52 per share, down from previous guidance of $16.10 to $16.60 per share. Eli Lilly also lowered the high-end of its revenue outlook for the year and now expects sales of between $45.4 billion and $46 billion. The weekly injection raked in $1.26 billion in sales for the period, below the $1.76 billion that analysts expected, according to StreetAccount. As of Wednesday, the Food and Drug Administration's drug database said all doses of Zepbound and Mounjaro are available in the U.S. after extended shortages.

Persons: Eli Lilly, Mounjaro, Eli Lilly's Organizations: Novo Nordisk, LSEG, Food Locations: U.S

☆ Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Several doses of semaglutide, the active ingredient in Wegovy and Ozempic, have been on the FDA's shortage list since early 2022. In a statement, Novo Nordisk said all doses of Wegovy and Ozempic are being shipped regularly to wholesalers. Still, Novo Nordisk said patients may not always be able to immediately fill their prescriptions at a particular pharmacy, even when a medication is listed as available. "Our intentional approach to gradually increase supply into the U.S. market is working," Novo Nordisk said.

Persons: Danish drugmaker, Eli Lilly, compounders Organizations: Novo Nordisk, U.S . Food, Nordisk, FDA Locations: Mitte, Germany, U.S, Danish, Novo

☆ Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
▼ + stars: | 2024-10-30 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +11 min

The report was messy, but it doesn't dim Eli Lilly's bright multiyear outlook, rendering the dip in the stock as a chance to buy. LLY .SPX 5Y mountain Eli Lilly's five-year stock performance compared with the S & P 500. Bottom line We're upgrading Eli Lilly to our buy-equivalent 1 rating and leaving our price target of $1,000 a share unchanged. Eli Lilly Why we own it: Eli Lilly's best-in-class drugs should enable growth above the industry average for many years to come. Eli Lilly's new Alzheimer's drug Kisunla, which was approved by the FDA in July, was not a major focus on the call.

Persons: Eli Lilly, Eli, Eli Lilly's, Jim Cramer, Jim, —, that's, David Ricks, Ricks, Semaglutide, Wegovy, Lilly, There's, Mounjaro, Trulicity, Verzenio, Jim Cramer's, Cristina Arias Organizations: Revenue, The Club, CNBC, JPMorgan, Novo Nordisk, Food, Novo Nordisk's, FDA, Zepbound, Biogen, Merck, Pfizer, Morphic, Company, Pharmaceutical Locations: Tuesday's, U.S, Novo, Eisai, FactSet, Zepbound, Alcobendas, Madrid, Spain

☆ Jim Cramer says CEOs must properly explain the bad news in every quarter
▼ + stars: | 2024-10-30 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer on Wednesday discussed the tricky nature of bad quarters, saying management needs to explain and not gloss over any misses or poor results. Cramer said every earnings shortfall is "nuanced beyond belief," with some more difficult for Wall Street to parse than others. The company, which had been seeing success with its popular weight loss and diabetes drugs, failed to properly explain its shortfall, Cramer said. And while management from Wingstop highlighted the bright spots of the quarter, they largely did not acknowledge the earnings miss, he continued. AMD, Eli Lilly and Wingstop did not immediately respond to request for comment.

Persons: CNBC's Jim Cramer, Cramer, Eli Lilly, Wingstop, Wednesday's, Eli Lilly's Organizations: Investors, AMD, Nvidia, Wingstop

☆ 20 Years of Impossible Choices in ‘Saw’
▼ + stars: | 2024-10-29 | by ( Annie Aguiar | Joyce Ho | ) www.nytimes.com time to read: +9 min

It can be hard to remember two decades later that the original “Saw” was less interested in gore than morality. In “Saw,” Cary Elwes’s character verbalizes the tension and appeal of the franchise: “He doesn’t want us to cut through our chains. “I’m going to try something else you haven’t seen before.”The classic tropes within “Saw” — serial killers, haunted detectives, creepy puppets — are mashed together and inverted around the undeniable binary of its core choice. In “Cube” (1997), an offbeat Canadian science fiction horror film, prisoners in a mysterious jail travel through rooms rigged with traps. Wan never directed another “Saw” movie, while Whannell contributed to “Saw II” and wrote the screenplay for “Saw III.”In the decades since “Saw” was released, Wan has directed tentpole franchise entries like “Aquaman” (2018) and “Furious 7” (2015).

Persons: Cary Elwes, ”, Shawnee Smith, ” Cary, Lionsgate Elwes, Westley, “, James Wan, Leigh Whannell, Wan, ” Wan, “ I’m, Rube Goldberg, David Edelstein, Eli Roth’s, John Kramer, Tobin Bell, Kramer, ” Bell, ” Whannell, Stacey Testro, Testro, Evolution Entertainment — Gregg Hoffman, Oren Koules, Mark Burg —, ” Burg, David Fincher’s “, “ Se7en, Morgan Freeman, Brad Pitt, Whannell, Se7en, —, Elisabeth Moss, ” Billy, Freddy Krueger Organizations: Royal Melbourne Institute of Technology, Shawnee, Lionsgate, Evolution Entertainment Locations: “, London, New York, Wan, Hollywood, United States

☆ Eli Lilly shares could be set for a big move if the Zepbound maker adds to its winning streak
▼ + stars: | 2024-10-29 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +6 min

Revenue from obesity treatment Zepbound is forecast to climb to $1.73 billion from $1.24 billion quarter over quarter. For the year, analysts expect Mounjaro sales to reach $4.58 billion, while Zepbound revenue is seen rising to $5.88 billion. The consensus view for combined sales of both drugs now stands at $30.19 billion, according to FactSet. Other key announcements A clinical trial is in progress that pits Zepbound against Novo Nordisk's Wegovy in obesity treatment. Beyond obesity, Lilly has begun treating patients with Kisunla, its Alzheimer's disease treatment.

Persons: Eli Lilly, Lilly, Seamus Fernandez, Morgan Stanley, Terence Flynn, David Risinger, Morgan Stanley's Flynn, Mounjaro, Cantor, Louise Chen, —, Fred Imbert Organizations: Investment, Food, Leerink, Novo Nordisk's, FDA, Kisunla Locations: U.S

☆ We're downgrading Honeywell shares, plus Starbucks makes a menu change
▼ + stars: | 2024-10-29 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. We will hear more about this broader strategy on the company's earnings call Wednesday night. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Wolfe, Oleato, Brian Niccol's, Eli Lilly, Jim Cramer's, Jim, Jeff Greenberg Organizations: CNBC, Nasdaq, Treasury, Honeywell, We're, Wolfe Research, Bloomberg, Starbucks, GE Healthcare . Caterpillar, Humana, Brinker International, Trane Technologies, Otis, Jim Cramer's Charitable, Universal, Getty Locations: Dover, Illinois, Atlanta , Georgia

☆ Google's new CFO makes earnings call debut, says company can 'push a little further' on cost cuts
▼ + stars: | 2024-10-29 | by ( Jennifer Elias | ) www.cnbc.com time to read: +3 min

For nine years, the CFO role at Google and parent company Alphabet was held by Ruth Porat, who took a giant pay package in 2015 to leave Wall Street for Silicon Valley. "But I think any organization can always push a little further and I'll be looking at additional opportunities." During the Q&A portion of the call, Evercore ISI's Mark Mahaney asked, "As you're coming in looking at this fresh, is it clear to you there are a lot of newfound cost efficiencies or ongoing cost efficiencies?" The new CFO said one way Google can find additional efficiencies is by using AI "within our own processes and how we get work done." WATCH: Google search benefiting from generative AI

Persons: Ruth Porat, Porat's, Anat Ashkenazi, Sundar Pichai, Ruth, Sundar, Ashkenazi, Eli Lilly, Porat, There's, Pichai, Askenazi, Evercore, Mark Mahaney Organizations: Google, Tuesday Locations: Silicon Valley

☆ 14 earnings reports and major economic data will be the stock market movers this week
▼ + stars: | 2024-10-27 | by ( Zev Fima | ) www.cnbc.com time to read: +15 min

The Street is looking for Stanley Black & Decker sales of $3.8 billion in the third quarter and earnings per share (EPS) of $1.05. The Street is looking for Linde sales of $8.35 billion in the third quarter and EPS of $3.89. In addition to the headline results and forward guidance, overall organic sales growth and data center energy power demand will be focus items for investors. The Street is looking for sales of $94.47 billion in its fiscal fourth quarter and EPS of $1.55. The Street is looking for Coterra sales of $1.3 billion in the third quarter and EPS of 34 cents.

Persons: That's, It's, Stanley Black, Decker, we're, We're, Eli Lilly, Lilly, Amy Hood's, Brian Niccol, Wednesday's, Linde, it's, we'll, Phillips, Horton, Kraft Heinz, SIRI, Estee Lauder, BUD, Cardinal Health, Jim Cramer's, Jim Cramer, Jim, Stephanie Keith Organizations: Nasdaq, Dow, Fed, PCE, YouTube, Justice, AMD, GE Healthcare, Reality Labs, Microsoft, Management, Starbucks, U.S, Presidential, Linde, Apple Intelligence, Amazon, Services, Coterra Energy, WM, Cadence Design Systems, Labor, PayPal, BP, Pfizer, Royal Caribbean Cruises, JetBlue, HSBC, Devices, Grill, Electronic Arts, EA, Gross, Caterpillar, Brinker International, AFortive Corporation, Illinois Tool, Coinbase, eBay, EBAY, Booking Holdings, MGM Resorts, MGM, Bausch Health, LIN, Merck, ConocoPhillips, Mastercard, Altria, Cruise, Myers Squibb, Comcast, Mobileye, Cheniere Energy, Regeneron Pharmaceuticals, Anheuser, Busch InBev, Intel, United States Steel, Juniper Networks, Chevron, Exxon Mobil, Dominion Energy, Charter Communications, LyondellBasell Industries, Cardinal, Jim Cramer's Charitable, CNBC, New York Stock Exchange, Getty Locations: Eaton, Corning, Illinois, Bristol, New York City

☆ How to dance the earnings two-step: Recognize initial stock distortions and then act
▼ + stars: | 2024-10-27 | by ( Jim Cramer | ) www.cnbc.com time to read: +18 min

For all we know, the yield curve may simply be going through the birthing of an un-inverted yield curve. GOOGL YTD mountain Alphabet YTD Search used to be so simple. META YTD mountain Meta Platforms YTD Meta Platforms has run big ahead of the quarter. AMZN YTD mountain Amazon YTD Let's get to the two toughest of the week, Amazon and Apple. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: let's, Eli Lilly, nonfarm payrolls, Carl Quintanilla, batty, Jeff Marks, Waymo, Elon Musk, Donald Trump, Kamala Harris, Department's, Mark Zuckerberg, Jensen Huang, Marc Benioff, Trump, Warren Buffett, Jim Cramer's, Jim Cramer, Jim Organizations: CNBC, Microsoft, Apple, Treasury, Federal Reserve, charlatans, Honeywell, Twitter, Club, Gemini, YouTube, Google, Donner Party of cannibalization, AMD, Nvidia, Intel, Merck, Pfizer, Tech Titans, Meta, Amazon Web Services Locations: Wall, cyclicals, California, Philly

☆ Big companies are seeing more turnover in the CFO chair. Here's why that matters
▼ + stars: | 2024-10-26 | by ( Morgan Chittum | ) www.cnbc.com time to read: +9 min

CFO turnover hit 8.9% globally during the period, surpassing levels in 2022 and 2023. A global pandemic, increased geopolitical tensions overseas, supply chain disruptions and recession concerns have made the CFO role even harder. Jim Cramer also has pounded the table of the importance of the CFO role, arguing that "a good CFO can give you a feeling of a Good Housekeeping seal of approval." Moving forward, it's unclear whether CFO turnover will continue to pickup. "If a CFO immediately resigns intra quarter, what companies will do sometimes is reaffirm their guidance to ease investor concerns.

Persons: Zachary Kirkhorn, Deepak Ahuja, Russell Reynolds, CFOs, Steve Gallucci, —, they've, Goldman Sachs, David Viniar, Josh Crist, Crist, Raymond James, Paul Shoukry, Jim Cramer, Amy Hood, Hood, we've …, Costco's Richard Galanti, Eli Lilly, Anat Ashkenazi, Ashkenazi, Ruth Porat, Apple, Luca Maestri, Amy Weaver, Mike Stepniak, Jeff Marks, Marks, It's, Jim Cramer's, Jim Organizations: Wall Street, Deloitte's Global, CNBC, Fortune, Goldman, Bloomberg News, Kolder, Microsoft, Honeywell, Federal, Jim Cramer's Charitable, Istock, Getty

Asian Americans now make up 12% of the electorate in Nevada, with Filipinos being the largest subgroup. In 2020, President Joe Biden won 64% of the state’s Asian American vote, while Trump took 35%. But in 2022, support in the Nevada governor’s race was more split among the local Asian American, Native Hawaiian and Pacific Islander community, which only voted blue by an 8% margin. But frankly, Covid, or as I call it, ‘the China virus,’ was a step too far,” he said. Trump took a moment to praise the Filipino community, saying he likes their clothes.

Persons: Donald Trump, Trump, Tulsi Gabbard, Vivek Ramaswamy, ” Trump, Joe Biden, Xi, ’, ”, Eli Michaels, “, ” Vivek Ramaswamy, Patrick T, Fallon, Harris, Trump’s, Charlie Kirk, Kamala Harris, Ramaswamy, Gabbard, “ He’s, Vivek Organizations: American, Pacific, Change, Hawaii Rep, GOP, Hispanic, NBC News, Getty, Nevada’s, Las, Indian American, Trump Locations: Las Vegas, “, Pacific Islander, Nevada, Hawaiian, China, AFP

☆ Tech is the star Friday, and why we'd be buyers of the dip on CrowdStrike
▼ + stars: | 2024-10-25 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street.

Persons: Jim Cramer, Carahsoft, George Kurtz, We'll, Stanley Black, Decker, Eli Lilly, Eaton, Brian Niccol's, It's, we'll, Jim Cramer's, Jim Organizations: CNBC, ., Nasdaq, Communication, Newmont Corporation, Nucor, Universal Health Services, HCA Healthcare, Bloomberg, Carahsoft Technology, Internal Revenue Service, IRS, Bloomberg News, Microsoft, Club, Nvidia, Devices, GE Healthcare, Nextracker, Linde, Coterra Energy, Starbucks, Federal, Boeing, Jim Cramer's Charitable Locations: U.S, China

☆ Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
▼ + stars: | 2024-10-25 | by ( Kristian Burt | In | ) www.cnbc.com time to read: +4 min

With massive corporations including Alphabet , Meta , Apple , Microsoft and Amazon set to report earnings next week, CNBC's Jim Cramer on Friday urged investors to keep a level head. "Just please remember, the first move's been the wrong move almost half the time since this earnings season began. Monday starts off the week with earnings from Ford . Tuesday brings McDonald's earnings report, and Cramer said to expect "a full airing of the e-coli situation," but that it is too early to tell how much damage it will do to the fast food chain. The monster week for earnings will continue into Thursday, as both Apple and Amazon will report after the bell.

Persons: CNBC's Jim Cramer, Cramer, Chipotle, Brian Niccol's, Eli Lilly, Meta, Chevron's, Hess, Exxon doesn't Organizations: Apple, Microsoft, Federal Reserve, Ford, Disease Control, Prevention, Royal, PayPal, Caterpillar, Meta, Merck, Bristol, Oil titans Chevron, Exxon, Chevron Locations: Gulf of Mexico, Myers

☆ Wall Street braces for a big week ahead of the election, with megacap tech earnings, key data on tap
▼ + stars: | 2024-10-25 | by ( Sarah Min | ) www.cnbc.com time to read: +5 min

Investors will contend with earnings results from five of the Magnificent Seven companies next week. .SPX 1M mountain S & P 500 "I sort of refer to this period that we're in right now as like a strange brew," said Mark Malek, investment chief at Siebert. On Friday, the Nasdaq Composite hit an all-time high , but the S & P 500 snapped a six-week win streak. In fact, the high concentration of the mega-cap leaders in the S & P 500 spurred Goldman Sachs' David Kostin this month to release a dim long-term forecast for the overall market. HSBC head of equity strategy Nicole Inui upped her S & P 500 year-end target to 5,900.

Persons: Mark Malek, Siebert, Goldman Sachs, David Kostin, Siebert's Malek, they've, Nicole Inui, Inui, D.R Horton, Price, Eli Lilly, Lauder Organizations: Microsoft, Meta, Apple, Nasdaq, U.S, Treasury, Big Tech, HSBC, FactSet, Richmond Fed, Dallas Fed, Ford, Semiconductor, Caesars Entertainment, Devices, Pfizer, Royal Caribbean Group, PayPal, ADP, Kraft Heinz, Caterpillar, GE Healthcare Technologies, Holdings, ECI Civilian Workers, PCE, PCE Deflator, Chicago PMI, Cruise Line Holdings, Uber Technologies, Lauder Companies, Mastercard, Generac, Jobs, PMI, Manufacturing, Exxon Mobil Locations: U.S, Chicago

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia. Another study, published in August, found that semaglutide appeared to cut the risk of dementia in people with Type 2 diabetes. Type 2 diabetes is a risk factor for dementia and Alzheimer’s. The study found that patients prescribed semaglutide had a significantly lower risk for Alzheimer’s disease than those who had taken one of the seven other diabetes drugs. The biggest difference was seen when comparing patients who took semaglutide to those who took insulin: Semaglutide patients had a 70% lower risk of Alzheimer’s, the study found.

Persons: —, semaglutide, ”, Stephen Salloway, ” Salloway, Rong Xu, liraglutide, Xu, ” Xu, they’re, Salloway, they’ve, Donna Wilcock, there’s, ” Wilcock, Dr, Alberto Espay, Espay, What’s, “, ” Espay Organizations: Alzheimer’s Association, Conference, Novo Nordisk, Warren Alpert Medical, Brown University, Center, Artificial Intelligence, Case Western Reserve University School of Medicine, Drug Administration, ”, Alzheimer’s, Indiana University School of Medicine, University of Cincinnati College of Medicine Locations: Novo, Rhode Island, Ohio

☆ Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
▼ + stars: | 2024-10-24 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Novo Nordisk 's blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer's disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday. Alzheimer's disease is often diagnosed in the mild dementia stage, when a person has significant trouble with memory and thinking. But the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S. by 2050. Novo Nordisk, which did not fund the new Case Western study, is also examining semaglutide in a late-stage study on Alzheimer's patients. In the liraglutide research, data from a midstage trial found that the drug may slow the progression of Alzheimer's disease by protecting patients' brains.

Persons: Semaglutide, Dr, Rong Xu, it's, Xu, Eli Lilly, Wegovy, Eli Lilly's Organizations: Novo Nordisk, Alzheimer's Association, Case Western Reserve University, CNBC, Nordisk, Case, National Institutes of Health, GLP Locations: U.S, Novo

☆ Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
▼ + stars: | 2024-10-23 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. The FDA still has to make a final decision on whether to bar compounded versions of semaglutide, the active ingredient in Ozempic and Wegovy. In a statement, the agency said it is reviewing the petition and will respond directly to Novo Nordisk. The active ingredient in Wegovy and Ozempic, semaglutide, has been in intermittent shortages over the past two years. Like Novo Nordisk, Eli Lilly has sued several weight loss clinics, medical spas and compounding pharmacies across the U.S. over the past year.

Persons: Wegovy, Danish drugmaker, semaglutide, Eli Lilly, Eli Lilly's, compounders Organizations: Novo Nordisk, Tuesday, Food and Drug Administration, FDA, Nordisk Locations: Novo, Danish, U.S

☆ KKM Financial's Essential 40 stock fund is now an ETF
▼ + stars: | 2024-10-21 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

KKM Financial has converted its Essential 40 mutual fund into an ETF, joining the growing shift by asset managers to a more tax-efficient fund model. "A lot of the wealth advisors that I work with really have issues with the capital gain distribution typical to a mutual fund." The newly converted KKM fund will trade on the Nasdaq under the ticker ESN. The old mutual fund version of the Essential 40 had a three-star rating from Morningstar. The ETF will have a net expense ratio of 0.70%, equal to that of the old mutual fund.

Persons: Jeff Kilburg, Eli Lilly, Morningstar, They've Organizations: KKM, CNBC, SEC, Securities and Exchange Commission, Nasdaq, JPMorgan Chase, Waste Management, Morningstar Locations: U.S

☆ Lilly sues online vendors, medical spa over copycat weight-loss drugs
▼ + stars: | 2024-10-21 | by ( ) www.cnbc.com time to read: +3 min

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. Pivotal Peptides says it offers research grade tirzepatide, while MangoRx sells a compounded version, both online. Lilly has accused Pivotal Peptides of selling products claiming to contain tirzepatide directly to patients without any prescription from a medical professional, despite advertising the drugs for research purposes. Lilly said it sent a cease and desist letter to Pivotal Peptides before filing the lawsuit. Eli Lilly is seeking court orders barring the vendors from selling their drugs claiming to contain tirzepatide and unspecified monetary damages.

Persons: Eli Lilly’s, Eli Lilly, tirzepatide, Lilly, MangoRx, drugmaker, Genesis Organizations: Lifestyle Medicine of, U.S . Food, Drug Administration, Genesis, FDA, B12 Locations: New York City, Lifestyle Medicine of Nevada, U.S, Indiana , Texas, Washington, Indianapolis

Search resuls for: "Eli Lilly

25 mentions found